Drill test newly modeled high-grade sub-zone targets scattered throughout the top 1,000 vertical metres from surface to ...
A myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...
Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...
CAMARILLO, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- via IBN - Newton Golf Company (Nasdaq: SPGC) ("Newton Golf" or the "Company"), a leader in premium golf equipment innovation, today announces that ...
A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...
On March 10, 2025, over 400 German municipalities will once again show their colors for Tibet. This is an important signal of ...
Health regulators in Canada gave conditionally approval to Qalsody to treat adults whose ALS is due to mutations in the SOD1 ...
Detailed price information for Altius Minerals Corp (ALS-T) from The Globe and Mail including charting and trades.
WE’RE HEARING FROM A WOMAN LIVING WITH ALS OR LOU GEHRIG’S DISEASE, WHO SAYS SHE MAY BE DIRECTLY IMPACTED BY THE TRUMP ADMINISTRATION’S FUNDING CUTS TO THE NATIONAL INSTITUTES OF HEALTH.